Study of the Consumption of a Food Supplement in a Group of Healthy People
Launched by IMDEA FOOD · Apr 2, 2018
Trial Information
Current as of July 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 18 and 55 years
- • Adequate understanding of the study.
- • Willingness to complete the entire treatment.
- Exclusion Criteria:
- • BMI \>30
- • Diagnosis of type 2 diabetes mellitus (T2D), hypertension, dyslipidemia or other cardiometabolic disorders
- • Impaired cognitive function;
- • Diagnosed hepatic, renal, or cardiovascular disease
- • Subjects with primary immunodeficiency disorders, consumption of drugs with influence on the immune system, splenectomy.
- • Presence of other pathologies like asthma, food allergies, Crohn's, myasthenia gravis, lupus
- • Consumption of vitamins, minerals, supplements of antioxidant extracts or protein supplements in the 2 weeks prior to the start of the study
- • Subjects treated with drugs affecting the lipid or glycemic profile during the previous 30 days
- • Consumption of anticoagulants or antiplatelet agents, cyclosporine, acetylsalicylic acid, antihistamines or sedatives
- • Hypersensitivity to rosemary, to its components or other members of the family of lipped plants or to soybean as excipient of the capsules
- • Allergy or hypersensitivity to fish
- • Habitual smoking or high consumption alcohol
- • Pregnant or lactating women
- • High-intensity physical exercise.
About Imdea Food
IMDEA Food is a leading research institute dedicated to advancing knowledge in the field of food science and nutrition. Based in Madrid, Spain, it focuses on promoting health and well-being through innovative research and development. The institute collaborates with academic, industrial, and governmental partners to address critical issues related to food quality, safety, and sustainability. IMDEA Food is committed to conducting high-quality clinical trials that contribute to evidence-based practices in nutrition and public health, ultimately aiming to improve dietary habits and health outcomes across populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, , Spain
Patients applied
Trial Officials
Guillermo Reglero, Proffesor
Study Director
IMDEA Food and Institute of Food Science Research (CIAL)
Ana Ramirez de Molina, PhD
Principal Investigator
IMDEA Food
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials